Du är här


aap Implantate AG: aap publishes annual financial statements for 2013

aap Implantate AG / aap publishes annual financial statements for 2013.
Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is
solely responsible for the content of this announcement.
Implantate AG has published today the annual financial statements for 2013.
The annual report 2013 is now available both in German and English on our
website (www.aap.de) and on our Investor-Relations-aap.

Publication of the interim report for the first quarter of 2014 is scheduled
for 15 May 2014.

Implantate AG (ISIN DE0005066609) - Prime Standard/Regulated Market - All
German stock markets -

Implantate AG
is a global medical device company headquartered in Berlin, Germany that
develops, manufactures and markets innovative biomaterials and implants that
are used in orthopedic procedures. The Company's products, which include a
full line of plating systems, cannulated screws and bone cement products, are
primarily used in the orthopedic specialty areas of trauma and spine repair.
The Company's products are sold through its direct sales force, distribution
partners and license agreements with OEM partners.aap
's stock is listed in the Prime Standard segment of the Frankfurt Stock
Exchange. For more information, please visit www.aap.de, or download the
Company's investor relations app from the Apple's App Store or Google Play.

Forward-looking statement
This release may contain forward-looking statements based on current
experience, estimates and projections of the management board and currently
available information. They are not guarantees of future performance. Various
known and unknown risks, uncertainties and other factors could lead to
material differences between the actual future results, financial situation,
development or performance of the company and the estimates given here. Many
factors could cause the actual results, performance or achievements of aap to
be materially different from those that may be expressed or implied by such
statements. These factors include those discussed inaap
's public reports. Forward-looking statements therefore speak only as of the
date they are made.aap
does not assume any obligation to update the forward-looking statements
contained in this release or to conform them to future events or

For inquiries please contact:aap
Implantate AG, Marc Heydrich, Investor Relations, Lorenzweg 5, 12099 Berlin,

Tel.: +49 30 7501 9-134, fax: +49 30 7501 9-290, e-mail: m.heydrich@aap


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: aap Implantate AG via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.